Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: AVP
Name: arginine vasopressin
Location: 20p13
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT01645475 Desmopressin Melt Impact on Sleep and Daytime Functioning View
NCT01056887 Copeptin in Differentiation of Polyuria and Polydipsia View
NCT03477461 Effects of Terlipressin on Management of Potential Organ Donors View
NCT01247090 Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease View
NCT03618420 Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function View
NCT03074214 Prognostic Value of Copeptin for Infarct Size and Prognosis in Patients With ST-elevation Myocardial Infarction View
NCT03389386 Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure View
NCT00573443 Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS View
NCT00795366 Vasopressin Versus Catecholamines for Cerebral Perfusion Pressure Control in Brain Injured Trauma Patients View
NCT03733873 Study on Chinese and Western Medicine in MNE Children View
NCT05491122 The Influence of Fluid Intake on Daily Biological Rhythm and Mental Performance in Healthy Young Adults View
NCT04447911 Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia View
NCT06422975 Registry of Patients in Shock Treated With Vasopressin View
NCT05920707 Common and Differentiated Representations Between Social Exclusion and Social Separation View
NCT06211985 Copeptin Disease Severity Indicator View
NCT06125184 Effect of Vasopressin on Kidney and Cardiac Function in Septic Shock View
NCT00160472 Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms View
NCT00447785 Endocrine Regulation of Energy and Fluid Supplies in Alcoholic Patients View
NCT00004363 Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus View
NCT00021697 SafetyEfficacy of AVP-923 in the Treatment of Emotional Lability Uncontrolled Crying Laughing in Patients With ALS View
NCT04363554 The Kidneys Ability to Concentrate and Dilute Urine in Patients With Autosomal Dominant Polycystic Kidney Disease View
NCT01271114 Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension View
NCT00380575 Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia View
NCT04408755 Assessment of the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type View
NCT00325065 Identifying the Role of Oxytocin and Vasopressin in the Functioning of Neurocognitive Systems Involved in Mood Disorders View
NCT00379847 An Open-Label Study of YM087 Conivaptan in Patients With Euvolemic or Hypervolemic Hyponatremia View
NCT00696605 Assessment of Circulating Copeptin Levels in Healthy Subjects and Patients With Renal Insufficiency After Oral Water Load and Hypertonic Saline Infusion View
NCT00811486 Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure View
NCT02205073 A Phase 1 Randomized Double-blind Placebo-controlled Crossover Study of RG7314 on the Potential Regulation of Higher Brain Functions in Healthy Male Participants Proof of Mechanism View
NCT02442765 Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type View
NCT02446132 Long Term Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type View
NCT02223429 Neurobiological Bases of Paternal Nurturance View
NCT01733134 Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment ACTIVATE View
NCT01202695 Safety and Pharmacokinetics Study of Human Monoclonal Antibody AVP-21D9 View
NCT01324232 Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis View
NCT02372981 Doppler-guided Haemorrhoidal Artery Ligation With Suture Mucopexy vs Suture Mucopexy Alone View
NCT01341665 Subclassification of the Syndrome of Inappropriate ADH Secretion View
NCT01566539 Biological Basis of Individual Variation in Social Cooperation View
NCT01584440 Efficacy Safety and Tolerability Study of AVP-923 DextromethorphanQuinidine for Treatment of Symptoms of Agitation in Participants With Alzheimers Disease View
NCT01687894 Vasopressin to Prevent Hypotension During Beach Chair Surgery View
NCT01767129 Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinsons Disease Patients View
NCT01787747 Pharmacokinetics PK and Tolerability of AVP-786 in Healthy Volunteers View
NCT05126732 Ganglion Cell Thickness in Enuresis Nocturna View
NCT04058106 Water Homeostasis in Propofol Based Total Intravenous Anesthesia View
NCT05188131 Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium View
NCT05215366 Value of Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital View
NCT02153502 Efficacy Safety and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment View
NCT02174835 A Phase-1 Study to Assess the Pharmacokinetics Safety and Tolerability of AVP-786 in Healthy Volunteers View
NCT02174822 A Phase 1 Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects View
NCT02336347 A Phase 1 Study Comparing AVP-786 With AVP-923 View
NCT05554237 A Study to Learn About the Study Medicine Called CTBAVP in Healthy Adult People View
NCT02402595 Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts View
NCT02477670 Efficacy Safety and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia View
NCT02534038 Safety Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition View
NCT02626832 Regulation of Arginine-vasopressin AVP View
NCT04326569 Copeptin in the Diagnosis of Post-operative Insipidus Diabetes After Pituitary Surgery View
NCT03014063 Vasopressin Plasma Concentrations in Patients Receiving Exogenous Vasopressin Infusion for Septic Shock View
NCT03175874 Autophagy and Pathological Aging View
NCT04890470 Effects of Oxytocin and Vasopressin on Moral Decision Making View
NCT03338920 Study to Assess the Safety and Efficacy of ONZETRA Xsail for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents View
NCT03381664 Study to Assess the Bioavailability Pharmacokinetics Safety and Tolerability of AVP-923 in Healthy Adult Participants View
NCT03393520 Assessment of the Efficacy Safety and Tolerability of AVP-786 Deudextromethorphan Hydrobromide d6-DMQuinidine Sulfate Q for the Treatment of Agitation in Patients With Dementia of the Alzheimers Type View
NCT03420222 Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder View
NCT06329037 The Effects of Oral Vasopressin on Attention Control An Eye-tracking Study View
NCT05008458 Value of Von Willebrand Factor and Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital View
NCT06593054 To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults View
NCT05890690 Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome View
NCT04464564 Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients with Dementia of the Alzheimers Type View
NCT04489823 PARADIGM Amplatzer Valvular Plug for PVL Closure View
NCT04591990 HYdrocortisone and VAsopressin in Post-RESuscitation Syndrome View
NCT04757285 Copeptin and Psychological Stress of Medic During COVID-19 Pandemic View
NCT00298753 Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine View
NCT00690586 Fluid Balance Hormones and Urine Proteomics in Nephrotic Syndrome in Childhood View
NCT00050232 Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients View
NCT05840874 Complications of Enterocystoplasty in Children View
NCT06036004 Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus View
NCT01327027 Vasopressin Effects on Human Social Communication View
NCT06329063 Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli An Eye-tracking Study View
NCT06344442 Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation AVENIR Trial View
NCT02068560 The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion View
NCT02084797 V2 Receptor Effects on Fluid Regulation and Performance View
NCT02096965 Use of Tolvaptan to Reduce Urinary Supersaturation a Pilot Proof of Principle Study View
NCT06604975 Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children View
NCT00056524 Safety Study of AVP-923 in the Treatment of IEED Involuntary Emotional Expression Disorder Also Known as Pseudobulbar Affect Episodes of Uncontrolled Crying andor Laughter View
NCT00589134 The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration View
NCT00806910 Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous Infusion View
NCT02442778 Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimers Type View
NCT02621736 Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis MEN View
NCT02874807 Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study View
NCT03095066 Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression Agitation and Irritability in Participants With Traumatic Brain Injury View
NCT03202667 Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study View
NCT03318601 Evaluation of Copeptin in Patients With Cirrhosis and Ascites View
NCT03693885 Oxytocin Administration Prior Planned Caesarean Section View
NCT03896945 Efficacy Safety and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia View